BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34204717)

  • 21. Association of Early-Stage Breast Cancer and Subsequent Chemotherapy With Risk of Atrial Fibrillation.
    Abdel-Qadir H; Thavendiranathan P; Fung K; Amir E; Austin PC; Anderson GS; Lee DS
    JAMA Netw Open; 2019 Sep; 2(9):e1911838. PubMed ID: 31539076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherence to guidelines for baseline staging in newly diagnosed localized breast cancer.
    DeMiglio L; Murdoch V; Ivison J; Voutsadakis IA
    Cancer Treat Res Commun; 2020; 22():100160. PubMed ID: 31677495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Staging of breast cancer: what standards should be used in research and clinical practice?
    Ravaioli A; Tassinari D; Pasini G; Polselli A; Papi M; Fattori PP; Pasquini E; Masi A; Alessandrini F; Canuti D; Panzini I; Drudi G
    Ann Oncol; 1998 Nov; 9(11):1173-7. PubMed ID: 9862046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rate of Distant Metastases on 18F-FDG PET/CT at Initial Staging of Breast Cancer: Comparison of Women Younger and Older Than 40 Years.
    Lebon V; Alberini JL; Pierga JY; Diéras V; Jehanno N; Wartski M
    J Nucl Med; 2017 Feb; 58(2):252-257. PubMed ID: 27587709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial.
    Hurvitz SA; Martin M; Symmans WF; Jung KH; Huang CS; Thompson AM; Harbeck N; Valero V; Stroyakovskiy D; Wildiers H; Campone M; Boileau JF; Beckmann MW; Afenjar K; Fresco R; Helms HJ; Xu J; Lin YG; Sparano J; Slamon D
    Lancet Oncol; 2018 Jan; 19(1):115-126. PubMed ID: 29175149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Neo-Bioscore Update for Staging Breast Cancer Treated With Neoadjuvant Chemotherapy: Incorporation of Prognostic Biologic Factors Into Staging After Treatment.
    Mittendorf EA; Vila J; Tucker SL; Chavez-MacGregor M; Smith BD; Symmans WF; Sahin AA; Hortobagyi GN; Hunt KK
    JAMA Oncol; 2016 Jul; 2(7):929-36. PubMed ID: 26986538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unwarranted imaging for distant metastases in patients with newly diagnosed ductal carcinoma in situ and stage I and II breast cancer.
    Lupichuk S; Tilley D; Surgeoner B; King K; Joy AA
    Can J Surg; 2020 Feb; 63(2):E100-E109. PubMed ID: 32109016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Planar Bone Scan Versus Computerized Tomography in Staging Locally Advanced Breast Cancer in Asymptomatic Patients: Does Bone Scan Change Patient Management Over Computerized Tomography?
    Bansal GJ; Vinayan Changaradil D
    J Comput Assist Tomogr; 2018; 42(1):19-24. PubMed ID: 28786907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
    Sanpaolo P; Barbieri V; Genovesi D
    Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [What do clinicians do with the results of the systematic staging imaging at the time of the breast cancer diagnosis?].
    Turpin A; Mailliez A; Vennin P; Bonneterre J
    Gynecol Obstet Fertil; 2014 May; 42(5):325-30. PubMed ID: 24411340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current and Emerging Therapies for HER2-Positive Women With Metastatic Breast Cancer.
    Porter K; Rosenzweig MQ
    J Adv Pract Oncol; 2017 Mar; 8(2):164-168. PubMed ID: 29900024
    [No Abstract]   [Full Text] [Related]  

  • 33. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.
    Garg AK; Strom EA; McNeese MD; Buzdar AU; Hortobagyi GN; Kuerer HM; Perkins GH; Singletary SE; Hunt KK; Sahin A; Schechter N; Valero V; Tucker SL; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):138-45. PubMed ID: 15093909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposals.
    Barthélémy P; Heitz D; Mathelin C; Polesi H; Asmane I; Litique V; Rob L; Bergerat JP; Kurtz JE
    Crit Rev Oncol Hematol; 2011 Aug; 79(2):196-204. PubMed ID: 20655243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Indication for bone scans in early breast cancer staging].
    de la Cueva L; Liévano P; Navarro P; Arroyo E; Añaños M; González M; García MC; Fuerte A; Colmenarejo F; Baringo T; Abós MD
    Rev Esp Med Nucl; 2009; 28(6):273-7. PubMed ID: 19995533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Need for Staging Investigations in Newly Diagnosed Breast Cancer: Establishing Local Guidelines for Radiological Staging in Bahrain.
    Alkazaz AA; Ali NF; Salman AZ; Almahari SA; Altaei TH; Albati WZ; Habib HM; Alsadoon AA; Almawlani NA; Alkhabbaz FA; Eid R; Abdulla HA
    Eur J Breast Health; 2024 Apr; 20(2):136-140. PubMed ID: 38571694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of 18F-FDG PET/CT imaging in breast cancer staging.
    Yararbas U; Avci NC; Yeniay L; Argon AM
    Bosn J Basic Med Sci; 2018 Feb; 18(1):72-79. PubMed ID: 28763628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline.
    Henry NL; Somerfield MR; Abramson VG; Ismaila N; Allison KH; Anders CK; Chingos DT; Eisen A; Ferrari BL; Openshaw TH; Spears PA; Vikas P; Stearns V
    J Clin Oncol; 2019 Aug; 37(22):1965-1977. PubMed ID: 31206315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial.
    von Minckwitz G; Colleoni M; Kolberg HC; Morales S; Santi P; Tomasevic Z; Zhang N; Hanes V
    Lancet Oncol; 2018 Jul; 19(7):987-998. PubMed ID: 29880292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data].
    Chen SY; Tang Y; Song YW; Wang SL; Jin J; Liu YP; Wang WH; Fang H; Ren H; Sun GY; Wang JY; Jing H; Zhang JH; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):619-625. PubMed ID: 30139034
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.